Tavenier, A. H.
Hermanides, R. S.
Ottervanger, J. P.
Rasoul, S.
Slingerland, R. J.
Tolsma, R.
van Workum, S.
Kedhi, E.
van ’t Hof, A. W. J.
Article History
First Online: 14 February 2019
Conflict of interest
: The ON-TIME 3 trial is funded by AstraZeneca and the Isala Academy. Dr. van ’t Hof reports institutional fees and non-financial support from AstraZeneca as well as grants from Medtronic. A.H. Tavenier, R.S. Hermanides, J.P. Ottervanger, S. Rasoul, R.J. Slingerland, R. Tolsma, S. van Workum and E. Kedhi declare that they have no competing interests.